A real dose-to-price table, which is rare
Most sellers here print a starting figure and let you find out at titration what the next dose costs. Midi prints the whole grid: every milligram tier against its own price, across four separate formulations, on one page.
That means the number you are quoted at the beginning is not the only number you can see. You can look up what your maintenance dose will cost before you start, which is the question that actually decides whether a program is affordable.
Midi also states that its medication prices include shipping and supplies, so the drug line has nothing hiding behind it. Read that as a scope statement about the medication, not about the visit.
The molecule is never named
Here is the thing to sit with. Midi's priced page calls its injectable a GLP-1 and its dual product a Dual-Action GLP-1/GIP. It does not say semaglutide. It does not say tirzepatide. A census across thirteen Midi pages found the word semaglutide twice, both inside an article's bibliography, and tirzepatide not at all.
So you can see exactly what your dose costs and not what your dose is. Those are different kinds of knowledge, and the second one is the one you would want before injecting something.
This review does not name the molecule either, because Midi has not, and guessing from the milligram ranges would be this site inventing a fact the seller declined to state. Three of the forty-nine sellers here label their products this way. Ask Midi directly, and get the answer before the first dose rather than after.
No membership fee is not the same as no fee
Midi's pricing page says it clearly: no membership fees, you only pay for your care and your medications. That is true, and it puts Midi among seventeen of the forty-nine sellers here that charge no membership.
Read the second half of that sentence. Care is a charge. A self-paying patient owes a first-visit fee and a lower fee for each follow-up, billed separately from the medication, and the site says plainly that prescriptions and labs are billed apart from the visit.
So the medication table is half the bill. Add the visit charge before you put Midi's figures next to a seller that folds everything into one monthly number, because those are not the same kind of number.
Insurance is the actual differentiator
Midi bills visits through insurance and names which plans. If you are covered, the consult side of the bill becomes a copay instead of a cash rate, which very little of this roster can offer at all.
That is the reason to choose Midi over a cash-pay competitor with a similar table. It changes the arithmetic more than any headline figure does.
Two limits. Patients on Medicare, Medicaid or Medi-Cal are excluded from the insurance route entirely. And the medication itself is not what insurance is being applied to here — the visits are.
A sublingual option, a named pharmacy and named clinicians
Midi prices a sublingual injectable-free option and a sublingual dual-action product in public. Five of the forty-nine sellers here quote any needle-free compounded product, and fewer still publish a dose ladder for one.
It names its compounding pharmacy in the terms of use. Ten of the forty-nine do that. It names individual clinicians with credentials on a dedicated page, plus a named advisory board. Thirty-one of the forty-nine name a prescriber.
The gap is on the brand side. Midi says it prescribes brand-name GLP-1s to a pharmacy of your choice, but names no brand and publishes no brand price, so a brand shopper leaves with nothing to compare.
Midi Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $165.9/moFrom the published table "GLP-1 Injectable pricing Dose Price 0.1 mg $165.90 ... 0.75 mg $270.90 ... 1.75 mg $340.00 ... 2.5 mg $355.00", headed "4-week supply / Cost includes shipping". Midi adds "Our medication prices include the cost of shipping and supplies." The molecule is never named on this page. | September 2026source |
| Glp-1 (compounded) | $210/moFrom the published table "Dual-Action GLP-1/GIP Injectable pricing Dose Price 1.25 mg $210.00 ... 3.75 mg $285.00 ... 7.5 mg $375.00 ... 15 mg $434.00", headed "4-week supply / Cost includes shipping". | September 2026source |
| Glp-1 (compounded-oral) | $164/moFrom the published table "GLP-1 Sublingual pricing Dose Price 0.075 mg $164.00 0.15 mg $235.00 0.24 mg $235.00 0.4 mg $255.00 0.8 mg $275.00", headed "4-week supply / Cost includes shipping". | September 2026source |
| Glp-1 (compounded-oral) | $209/moFrom the published table "Dual-Action GLP-1/GIP Sublingual pricing Dose Price 1 mg $209.00 3.5 mg $245.00 5 mg $370.00 6 mg $370.00 7 mg $460.00", headed "4-week supply / Cost includes shipping". | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 56 providers reviewed here are paid partners today; the other 52 are not. See how this works.
See Midi Health's current price →Good fit if
- Women in perimenopause or menopause who want weight care inside a practice built around midlife rather than bolted onto it.
- Patients with insurance, since the visit is billable and becomes a copay rather than a cash charge.
- Anyone who wants the price of their own milligram dose before starting rather than a starting figure and a surprise at titration.
- People who want a needle-free option quoted at a published price, which only five of the forty-nine sellers here offer at all.
Look elsewhere if
- Anyone who needs to know which molecule they are taking. Midi labels its products only as GLP-1 and GLP-1/GIP; Cora Health, Maximus and Zappy Health each name the drug beside every figure.
- Patients on Medicare, Medicaid or Medi-Cal, who are excluded from Midi's insurance route.
- Buyers who want a single all-in monthly charge. A self-paying Midi patient owes a visit fee on top of the medication; Cora Health, Henry Meds and Ivím Health each fold everything into one figure.
- Brand-name shoppers. Midi prescribes brands but names none and prices none; Alloy, Dr. B and Maximus all publish brand figures.
How this review was verified
- Read the GLP-1 pricing page at its source URL and logged the published dose-to-price table for all four formulations, with the date read.
- Recorded the compound as unspecified rather than inferred, after a census across thirteen Midi pages found semaglutide only inside an article bibliography and tirzepatide not at all.
- Logged the no-membership claim verbatim and recorded beside it the self-pay visit charges, so the medication figures can never render as a complete monthly bill.
- Carried the shipping-and-supplies inclusion into the qualifier on every figure, because that is the scope Midi states for the medication line specifically.
- Read the terms of use for the pharmacy question and logged the compounding pharmacy Midi names there.
- Recorded both of Midi's coverage statements — the fifty-state claim and the eligibility-and-state qualifier that sits on the same site — rather than choosing between them.
- Checked the brand-name claim and confirmed that no brand is named and no brand price is published, so no brand price row exists on the record.